VMD Chief Medical Officer William Frazier Sells $117K of Stock

William Frazier Executes Insider Sale of Viemed Healthcare Shares

Viemed Healthcare, Inc. (NasdaqCM: VMD) Chief Medical Officer William Frazier sold 10,000 shares of the company stock on June 25, 2026. The transaction took place at a price of $11.72 per share, bringing the total value of the sale to $117,200. Insider transactions are routine events for publicly traded companies and do not inherently signal a positive or negative outlook from the executives involved.

Recent Insider Activity at Viemed Healthcare

This filing follows a busy week of executive transactions for the medical device firm. On the same day as his sale, Frazier also logged a separate acquisition of 10,000 shares at a price of $1.81 per share valued at $18,100. Just a day prior on June 24, 2026, insider Timothy Smokoff sold 20,000 shares at an average price of $11.50 for a total of $229,968. These disclosures offer a look into how company leaders manage their personal equity holdings over time.

Viemed Healthcare Stock Performance and Valuation

Viemed Healthcare shares traded at $11.63, sitting comfortably above the 200-day moving average of $9.25 and near the upper end of its 52-week trading range of $6.05 to $12.61. The company carries a market capitalization of roughly $337.08 million and a P/E ratio of 24.58 based on trailing earnings. With a forward P/E ratio of 22.13, the valuation reflects expectations for steady earnings ahead in the medical devices sector.

Analysts Set New Price Targets

Wall Street firms maintain active coverage on the medical device provider, with two analyst opinions on record. Barrington Research initiated coverage on August 24, 2026, with an Outperform rating and a $14.00 price target. Earlier on August 6, 2026, Freedom Broker issued a downgrade to a Hold rating alongside an $11.00 price target. The current consensus points to a target mean price of $12.50.

Home Medical Equipment Provider Background

Viemed Healthcare, Inc. provides home medical equipment and post-acute respiratory healthcare services across the United States. The company specializes in chronic obstructive pulmonary disease management solutions, ventilators, positive airway pressure machines, and related sleep apnea treatments. Headquartered in Lafayette, Louisiana, the firm employs a team of 1,438 people to support patient care and medical equipment delivery.

Looking Ahead for VMD Stock

Investors tracking Viemed Healthcare can look forward to the company's next earnings report, which is expected around November 4, 2026. Future regulatory filings with the SEC will provide further updates on insider ownership changes and institutional portfolio shifts as the fiscal year progresses.